{"ticker": {"uuid": "e3dd5ff9-c54a-457d-9926-695c733d5623", "symbol": "688222", "name": "HitGen Inc.", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgJBVV95cUxOX3pXX3JGTXAzUEpRWk42a1JFLWctbkhoUUd3RkhvaUlTVUFTMUxOeFZxUDlQVjFUb0I5VXZDeWlnSU1RdEdWcWlvR054TGI4ZmVLa0hUbFd2bmZOdlNFdHljeEVmVlJ6TnFTYTltTEk2UU5nd2hWMVNkRmw2YTBBQ2haNW9WTk1QaGpTS2NvYVUwYTg0YVl2LV94SVp0SVFQR1dpdUdEamtPQm8xSlZweVV5QVN1LWxGWEYtOXJ3eXJVVnVKRE44Q0JkNkpEejk3UVc2VWFLQ1RTZ043WHNtMy1mNW5RU0NrTHBqV3lhOU5NNF92bm9YZVpYdWl2ck8wTl85MUo4V0IzQTdFS0E?oc=5", "source_name": "BioSpace", "published_at": "2026-07-15T01:05:10+00:00", "published_display": "15 Jul 2026 01:05", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HitGen Receives New Funding to Discover Novel Therapeutics for Underserved Diseases", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNUEFtN1lmSmFmRFJkY2R3VUFwdENUeEJGNE1kekF0dGlkVG9TOWNYRnJjUHFlczdwa181WkVDZlJFV1RrMjJVaTJlMDlNbG5iVk12czZtVWs4Nk05VUNKS2hENTQ5d1psU19reHF6OTdnZDNUaFpyanFMVWRDYmQ0ZGlGd0ViZktWbS1MUlR2TGhuOWdKa18xMU1mWk0xd2dSQUp4d3dpU1Q5UzJwcTFVelk0ZTNHTHZnWjFqdjFDQzNDd3lXQXNKY2QzQXVCc1ZrS3hBTWhR?oc=5", "source_name": "PR Newswire", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HitGen Announces Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNQmVQWFlkMHpwdmItN3E5dkZXb3F6dXJTNExhR2x6V1dzOW16RDBON3NFUDdCYkxKQWFHOU5DdGx5akpWQ1c3R1ZGdlY5LWQyalVqWTFtY2ZXR1BpUEI2QmhDN1Z2azhOTS1VbHRUY3VXdmFvR0Jkb2oxV0R3M0lpVGdqdVJLWG1hVEZIcFhYM2k4ZmtJVXVNd1ZQUFFfbEc1Qm9UblUzYlRzTmJwY0FER3NtRHEwLU9fdVpoalp3LVJwMzB0ejJkTWJFQVdjcUNBMm5NZzRBZjZwWHhtanVSbw?oc=5", "source_name": "PR Newswire", "published_at": "2022-03-17T07:00:00+00:00", "published_display": "17 Mar 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgJBVV95cUxOX3pXX3JGTXAzUEpRWk42a1JFLWctbkhoUUd3RkhvaUlTVUFTMUxOeFZxUDlQVjFUb0I5VXZDeWlnSU1RdEdWcWlvR054TGI4ZmVLa0hUbFd2bmZOdlNFdHljeEVmVlJ6TnFTYTltTEk2UU5nd2hWMVNkRmw2YTBBQ2haNW9WTk1QaGpTS2NvYVUwYTg0YVl2LV94SVp0SVFQR1dpdUdEamtPQm8xSlZweVV5QVN1LWxGWEYtOXJ3eXJVVnVKRE44Q0JkNkpEejk3UVc2VWFLQ1RTZ043WHNtMy1mNW5RU0NrTHBqV3lhOU5NNF92bm9YZVpYdWl2ck8wTl85MUo4V0IzQTdFS0E?oc=5", "source_name": "BioSpace", "published_at": "2026-07-15T01:05:10+00:00", "published_display": "15 Jul 2026 01:05", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HitGen Receives New Funding to Discover Novel Therapeutics for Underserved Diseases", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNUEFtN1lmSmFmRFJkY2R3VUFwdENUeEJGNE1kekF0dGlkVG9TOWNYRnJjUHFlczdwa181WkVDZlJFV1RrMjJVaTJlMDlNbG5iVk12czZtVWs4Nk05VUNKS2hENTQ5d1psU19reHF6OTdnZDNUaFpyanFMVWRDYmQ0ZGlGd0ViZktWbS1MUlR2TGhuOWdKa18xMU1mWk0xd2dSQUp4d3dpU1Q5UzJwcTFVelk0ZTNHTHZnWjFqdjFDQzNDd3lXQXNKY2QzQXVCc1ZrS3hBTWhR?oc=5", "source_name": "PR Newswire", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HitGen Announces Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNQmVQWFlkMHpwdmItN3E5dkZXb3F6dXJTNExhR2x6V1dzOW16RDBON3NFUDdCYkxKQWFHOU5DdGx5akpWQ1c3R1ZGdlY5LWQyalVqWTFtY2ZXR1BpUEI2QmhDN1Z2azhOTS1VbHRUY3VXdmFvR0Jkb2oxV0R3M0lpVGdqdVJLWG1hVEZIcFhYM2k4ZmtJVXVNd1ZQUFFfbEc1Qm9UblUzYlRzTmJwY0FER3NtRHEwLU9fdVpoalp3LVJwMzB0ejJkTWJFQVdjcUNBMm5NZzRBZjZwWHhtanVSbw?oc=5", "source_name": "PR Newswire", "published_at": "2022-03-17T07:00:00+00:00", "published_display": "17 Mar 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 52, "total_relevant": 3, "sentiment_summary": {"positive": 0, "negative": 1, "neutral": 2, "score": 44, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}], "positive_events": 0, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 29.7, "latest_week": "2026-07-17", "one_week_move": -17.2, "four_week_move": 7.9, "twelve_week_move": 13.7, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.976358, "market_dynamics_buy_signal": false, "relative_strength": 17.73498, "fair_value_gap": 65.9, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 47.2562, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-17.2% over one week, +7.9% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "PR Newswire", "count": 2}, {"label": "BioSpace", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "44/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-17.2% over one week, +7.9% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction"}], "updated_at": "2026-07-24T14:11:21.693415+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}